ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Respiratory Health of Elite Athletes (cold air)

This study is currently recruiting participants.
Verified by Laval University, April 2008

Sponsored by: Laval University
Information provided by: Laval University
ClinicalTrials.gov Identifier: NCT00686491
  Purpose

Eleven National Sports Teams are located in the Quebec Metropolitan Area. In these groups, many athletes are aiming for Olympic medals in Beijing 2008 and Vancouver 2010 Olympic Games. A consultation of the coaches of these National Teams revealed that although a large proportion of these athletes present various cardio-respiratory symptoms, they do not have a rapid access to a systematic medical evaluation and follow-up. Furthermore, little is done in regard to prevention and optimization of treatment of pulmonary and cardiac conditions in the elite athlete's population of the Quebec area.

Cardiorespiratory problems are therefore commonly found in high-level athletes. However, these pathologies are not well characterized in athletes and the associated symptoms often not well perceived. These problems can be serious and it is important to detect them before they appear1 while setting up a systematic medical follow-up. Health professionals should monitor health of the young athletes and help to reduce the risks associated with high level exercise. The following project is an evaluation and follow-up program of high-level athletes, aiming at gathering key-information on long-term effects of high-level training on cardio-respiratory and metabolic parameters. Our aims will be

  1. to establish a long-term program of systematic evaluation and follow-up of cardiorespiratory health and performance of high elite athletes.
  2. to evaluate the prevalence of respiratory, circulatory and metabolic problems among high-level athletes
  3. to evaluate the effects of treatments on cardiorespiratory conditions and exercise performance in athletes who need asthma medication.

Condition
Asthma
Cardiovascular Diseases
Metabolic Diseases

MedlinePlus related topics:   Asthma    Metabolic Disorders   

U.S. FDA Resources

Study Type:   Observational
Study Design:   Case Control, Prospective
Official Title:   Center of Excellence in CardioRespiratory Health of High-Level Athletes: Evaluation of Long-Term Effects of Training.

Further study details as provided by Laval University:

Biospecimen Retention:   Samples With DNA

Biospecimen Description:

Serum - plasma - sputum


Estimated Enrollment:   100
Study Start Date:   June 2007
Estimated Study Completion Date:   December 2010
Estimated Primary Completion Date:   December 2010 (Final data collection date for primary outcome measure)

Groups/Cohorts
1
Triathletes
2
Cold air athletes
3
Swimmers
4
Other sports elite athletes
5
Control subjects

  Eligibility
Ages Eligible for Study:   14 Years to 45 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample

Study Population

Athletes training in the province of Quebec. Controls from Quebec schools and universities.


Criteria

Inclusion Criteria:

  • Athletes training more than 10 hours per week-

Exclusion Criteria:

  • asthma or other pathologies that may interfere with the study
  • Smokers
  • Obese of with a BMI more than 29
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00686491

Contacts
Contact: Julie TURMEL, PhD     418-656-8711 ext 2814     julie.turmel@crhl.ulaval.ca    
Contact: Paul Poirier, MD     418-656-8711     paul.poirier@crhl.ulaval.ca    

Locations
Canada
Centre de recherche en pneumologie et cardiologie de l'hôpital Laval     Recruiting
      Quebec, Canada, G1V4G5
      Contact: Julie TURMEL, MSc     418-656-8711 ext 2814     julie.turmel@crhl.ulaval.ca    
      Contact: Paul POIRIER, MD     418-656-8711     jpaul.poirier@crhl.ulaval.ca    
      Principal Investigator: Louis-Philippe BOULET, MD            
      Principal Investigator: Paul POIRIER, MD            

Sponsors and Collaborators
Laval University

Investigators
Principal Investigator:     Paul POIRIER, MD     Hôpital LAval    
Principal Investigator:     Paul POIRIER, MD     Hôpital Laval    
  More Information


Responsible Party:   Hôpital Laval ( Dr Louis-Philippe BOULET )
Study ID Numbers:   CER 20141
First Received:   May 26, 2008
Last Updated:   May 28, 2008
ClinicalTrials.gov Identifier:   NCT00686491
Health Authority:   Canada: Canadian Institutes of Health Research

Keywords provided by Laval University:
Asthma  
Environment  
Type of sport  
cardiovascular disease  
Athletes  

Study placed in the following topic categories:
Hypersensitivity
Lung Diseases, Obstructive
Metabolic Diseases
Respiratory Tract Diseases
Lung Diseases
Hypersensitivity, Immediate
Asthma
Metabolic disorder
Respiratory Hypersensitivity

Additional relevant MeSH terms:
Immune System Diseases
Bronchial Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on October 15, 2008




Links to all studies - primarily for crawlers